Active Motif Incorporated license covers targeted transposition for Diagenode SA Technology

Carlsbad, Calif., 31 July 2022 /PRNewswire/ — Active Motif Incorporated, a company with a vision to bring epigenetics more deeply into precision medicine, announced that it has granted its fundamental patents in transposition to Diagenode SA, a homologous company, for use in cut-and-tag epigenetic assays. non-exclusively licensed (Nasdaq: HOLX). The innovations underlying these patents allow mechanistic, translational and clinical researchers to interrogate open chromatin with the goal of gaining an increased understanding of biological processes. Through a licensing arrangement, Diagenode gains access to Active Motif’s patents., Including US9938524, EP2783001, US10689643, US11306307, EP 2999784, and other related patent applications.

Cut&Tag-IT, owned by Active Motif. details about tm Technology . can be seen on

About Active Motif
Active Motif, Inc. Dedicated to the development, manufacture and delivery of epigenetics-based research tools to analyze nuclear function. Its clients include scientists from academic and government institutions; Biotechnology and pharmaceutical companies. Active Motif operates globally through its corporate headquarters Carlsbad, California and office Shanghai, China, Tokyo, Japan and Waterloo Belgium. Active Motif applies a multi-disciplinary approach to innovate and modify existing technologies to meet the current and future needs of life science researchers.

media Contact: Fritz EibelActive shape included, [email protected]

source active shape

Source link

Read |  Verizon won't install technology to pinpoint 911 calls from cellphones in Colorado